Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26 USD | +0.79% | +1.17% | +14.70% |
Mar. 14 | Barrington Ups Price Target on Anika Therapeutics to $37 From $29, Keeps Outperform Rating | MT |
Mar. 13 | Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 |
Financials (USD)
Sales 2024 * | 170M | Sales 2025 * | 182M | Capitalization | 378M |
---|---|---|---|---|---|
Net income 2024 * | -2M | Net income 2025 * | 6M | EV / Sales 2024 * | 2.22 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.08 x |
P/E ratio 2024 * |
-168
x | P/E ratio 2025 * |
62.4
x | Employees | 357 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.4% |
Latest transcript on Anika Therapeutics, Inc.
1 day | -0.62% | ||
1 week | +1.10% | ||
Current month | +1.54% | ||
1 month | +1.30% | ||
3 months | +12.62% | ||
6 months | +38.66% | ||
Current year | +13.81% |
Managers | Title | Age | Since |
---|---|---|---|
Cheryl Blanchard
CEO | Chief Executive Officer | 59 | 18-08-30 |
Michael Levitz
DFI | Director of Finance/CFO | 50 | 20-08-09 |
Anne Nunes
COO | Chief Operating Officer | 55 | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Vogt
BRD | Director/Board Member | 70 | 18-10-22 |
Sheryl Conley
BRD | Director/Board Member | 63 | 21-10-27 |
Cheryl Blanchard
CEO | Chief Executive Officer | 59 | 18-08-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.32% | 27 M€ | -4.16% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 25.99 | +0.78% | 17 706 |
24-04-23 | 25.79 | -0.62% | 35,868 |
24-04-22 | 25.95 | +0.43% | 37,540 |
24-04-19 | 25.84 | +1.61% | 49,278 |
24-04-18 | 25.43 | -1.01% | 83,322 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.81% | 378M | |
-2.86% | 87.37B | |
+4.08% | 41.01B | |
-25.35% | 28.08B | |
+53.74% | 24.72B | |
-4.52% | 17.47B | |
-42.09% | 11.69B | |
-17.77% | 11.6B | |
-12.10% | 11.56B | |
+1.35% | 8.44B |
- Stock Market
- Equities
- ANIK Stock